Related Experiment Video
Updated: Aug 7, 2026
09:48
Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
Published on: May 4, 2015
[Reversible postpartum cerebral angiopathy associated with bromocriptine therapy]
1Service de Neurologie, Centre Hospitalier François Mitterrand, Pau. bruno.barroso@ch-pau.fr
Revue Neurologique
|December 17, 2004
Summary
Postpartum women using bromocriptine for lactation suppression may develop serious cerebral angiopathy. Early drug withdrawal led to complete recovery, highlighting the importance of clinician awareness.
Area of Science:
- Neurology
- Obstetrics
- Pharmacology
Background:
- Postpartum is a significant risk factor for stroke.
- Bromocriptine, used for lactation suppression, may induce cerebral angiopathy.
Observation:
- A 26-year-old postpartum woman experienced headaches, seizures, hypertension, and acute renal failure eight days after starting bromocriptine.
- Brain MRI revealed multiple cortical signal abnormalities and segmental arterial narrowings, indicative of intracranial vasculitis.
Findings:
- Bromocriptine was the likely cause of the adverse cerebral and systemic event.
- The patient fully recovered within one week of discontinuing bromocriptine.
- Biological and radiological abnormalities were reversible upon drug withdrawal.
Implications:
- Clinicians must be aware of bromocriptine-related postpartum cerebral angiopathy.
- This rare but serious complication can occur with bromocriptine use for postpartum breast engorgement.
- Prompt recognition and drug cessation are crucial for patient recovery.
